Results 151 to 160 of about 1,457 (176)

Understanding and targeting senescence in kidney disease. [PDF]

Clin Kidney J
Chanvillard L, Mason T, Ferenbach DA.
europepmc   +1 more source

Correction to "Rutin is a Potent Senomorphic Agent to Target Senescent Cells and Can Improve Chemotherapeutic Efficacy". [PDF]

Aging Cell
europepmc   +1 more source

Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in chronic kidney disorder induced vascular calcification. [PDF]

Int J Immunopathol Pharmacol
Arora S, Halsey G, Zohora FT, Swiss A, Vyavahare N.   +4 more
europepmc   +1 more source

Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies. [PDF]

J Cardiovasc Aging
Mahoney SA, Bloom SI, Seals DR, Donato AJ, Rossman MJ, Clayton ZS.   +5 more
europepmc   +1 more source

Drugs and Healthy Aging. [PDF]

Drugs Aging
Hilmer SN, Ferrucci L, Cherubini A.
europepmc   +1 more source

Nicotinamide Mononucleotide Decreases Secretion of Proinflammatory Cytokines via the NAD <b>⁺</b> /SIRT1/p65 Axis. [PDF]

ACS Omega
Zhang D, Li Z, Meng X, Wang T, Miao Z, Deng H.   +5 more
europepmc   +1 more source

The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion. [PDF]

Front Oncol
Xing Y, Qin G, Lin X, Chen S, Su Y, Lin T, Chen G.   +6 more
europepmc   +1 more source

An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence [PDF]

Baker DJ, Brown DA, Burma S, Burns TC, Carlstrom LP, Ikram S, Kirkland JL, Kizilbash SH, Mansour MA, Mukherjee B, Neth BJ, Olson IE, Rahman M, Rajani K, Riviere-Cazaux C, Schafer MJ, Short SC, Tchkonia T, von Zglinicki T, Warrington AE   +19 more
core